CA Patent

CA2342981A1 — Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin

Assigned to Warner Lambert Co LLC · Expires 2000-04-06 · 26y expired

What this patent protects

Acetyldinaline in combination with gemcitabine, a pharmaceutically acceptable salt thereof, capecitabine, or cisplatin is synergistic for treating cancer.

USPTO Abstract

Acetyldinaline in combination with gemcitabine, a pharmaceutically acceptable salt thereof, capecitabine, or cisplatin is synergistic for treating cancer.

Drugs covered by this patent

Patent Metadata

Patent number
CA2342981A1
Jurisdiction
CA
Classification
—
Expires
2000-04-06
Drug substance claim
No
Drug product claim
No
Assignee
Warner Lambert Co LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.